The effects of elevated hemoglobin A1c in patients with type 2 diabetes mellitus on dental implants: Survival and stability at one year

Research output: Contribution to journalArticle

  • 9 Citations

Abstract

Background.The authors conducted a prospective cohort study to determine whether poor glycemic control is a contraindication to implant therapy in patients with type 2 diabetes.

Methods. The study sample consisted of 117 edentulous patients, each of whom received two mandibular implants, for a total of 234 implants. Implant-retained mandibular overdentures were loaded after a four-month healing period and followed up for an additional one year. The authors assessed implant survival and stability (by means of resonance frequency analysis) relative to glycated hemoglobin A1c (HbA1c) levels, with baseline levels up to 11.1 percent and levels as high as 13.3 percent over one year.

Results. Implant survival rates for 110 of 117 patients who were followed up for one year after loading were 99.0 percent, 98.9 percent and 100 percent, respectively, for patients who did not have diabetes (n = 47), those with well-controlled diabetes (n = 44) and those with poorly controlled diabetes (n = 19). The authors considered the seven patients lost to follow-up as having had failed implants; consequently, their conservative estimates of survival rates in the three groups were 93.0 percent, 92.6 percent and 95.0 percent (P = .6510). Two implants failed at four weeks, one in the nondiabetes group and the other in the well-controlled diabetes group. Delays in implant stabilization were related directly to poor glycemic control.

Conclusions. The results of this study indicate that elevated HbA1c levels in patients with type 2 diabetes were not associated with altered implant survival one year after loading. However, alterations in early bone healing and implant stability were associated with hyperglycemia. Practical Implications. Within the clinical parameters of this study, the findings indicate likely implant success among patients with type 2 diabetes who lacked good glycemic control. Further investigation, including longer-term evaluation, is needed.

Original languageEnglish (US)
Pages (from-to)1218-1226
Number of pages9
JournalJournal of the American Dental Association
Volume145
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Dental Implants
Type 2 Diabetes Mellitus
Hemoglobins
Survival Rate
Overlay Denture
Hemoglobin A
Lost to Follow-Up
Glycosylated Hemoglobin A
Hyperglycemia
Cohort Studies
Prospective Studies
Bone and Bones

Keywords

  • Bone biology
  • Diabetes
  • Implant stability quotient
  • Implantology
  • Resonance frequency analysis

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

@article{649cc14800e34908af669e6a2e5e5e5d,
title = "The effects of elevated hemoglobin A1c in patients with type 2 diabetes mellitus on dental implants: Survival and stability at one year",
abstract = "Background.The authors conducted a prospective cohort study to determine whether poor glycemic control is a contraindication to implant therapy in patients with type 2 diabetes.Methods. The study sample consisted of 117 edentulous patients, each of whom received two mandibular implants, for a total of 234 implants. Implant-retained mandibular overdentures were loaded after a four-month healing period and followed up for an additional one year. The authors assessed implant survival and stability (by means of resonance frequency analysis) relative to glycated hemoglobin A1c (HbA1c) levels, with baseline levels up to 11.1 percent and levels as high as 13.3 percent over one year.Results. Implant survival rates for 110 of 117 patients who were followed up for one year after loading were 99.0 percent, 98.9 percent and 100 percent, respectively, for patients who did not have diabetes (n = 47), those with well-controlled diabetes (n = 44) and those with poorly controlled diabetes (n = 19). The authors considered the seven patients lost to follow-up as having had failed implants; consequently, their conservative estimates of survival rates in the three groups were 93.0 percent, 92.6 percent and 95.0 percent (P = .6510). Two implants failed at four weeks, one in the nondiabetes group and the other in the well-controlled diabetes group. Delays in implant stabilization were related directly to poor glycemic control.Conclusions. The results of this study indicate that elevated HbA1c levels in patients with type 2 diabetes were not associated with altered implant survival one year after loading. However, alterations in early bone healing and implant stability were associated with hyperglycemia. Practical Implications. Within the clinical parameters of this study, the findings indicate likely implant success among patients with type 2 diabetes who lacked good glycemic control. Further investigation, including longer-term evaluation, is needed.",
keywords = "Bone biology, Diabetes, Implant stability quotient, Implantology, Resonance frequency analysis",
author = "Oates, {Thomas W.} and Patrick Galloway and Peggy Alexander and Green, {Adriana Vargas} and Guy Huynh-Ba and Jocelyn Feine and Mcmahan, {C. Alex}",
year = "2014",
month = "12",
doi = "10.14219/jada.2014.93",
volume = "145",
pages = "1218--1226",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "12",

}

TY - JOUR

T1 - The effects of elevated hemoglobin A1c in patients with type 2 diabetes mellitus on dental implants

T2 - Journal of the American Dental Association

AU - Oates,Thomas W.

AU - Galloway,Patrick

AU - Alexander,Peggy

AU - Green,Adriana Vargas

AU - Huynh-Ba,Guy

AU - Feine,Jocelyn

AU - Mcmahan,C. Alex

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background.The authors conducted a prospective cohort study to determine whether poor glycemic control is a contraindication to implant therapy in patients with type 2 diabetes.Methods. The study sample consisted of 117 edentulous patients, each of whom received two mandibular implants, for a total of 234 implants. Implant-retained mandibular overdentures were loaded after a four-month healing period and followed up for an additional one year. The authors assessed implant survival and stability (by means of resonance frequency analysis) relative to glycated hemoglobin A1c (HbA1c) levels, with baseline levels up to 11.1 percent and levels as high as 13.3 percent over one year.Results. Implant survival rates for 110 of 117 patients who were followed up for one year after loading were 99.0 percent, 98.9 percent and 100 percent, respectively, for patients who did not have diabetes (n = 47), those with well-controlled diabetes (n = 44) and those with poorly controlled diabetes (n = 19). The authors considered the seven patients lost to follow-up as having had failed implants; consequently, their conservative estimates of survival rates in the three groups were 93.0 percent, 92.6 percent and 95.0 percent (P = .6510). Two implants failed at four weeks, one in the nondiabetes group and the other in the well-controlled diabetes group. Delays in implant stabilization were related directly to poor glycemic control.Conclusions. The results of this study indicate that elevated HbA1c levels in patients with type 2 diabetes were not associated with altered implant survival one year after loading. However, alterations in early bone healing and implant stability were associated with hyperglycemia. Practical Implications. Within the clinical parameters of this study, the findings indicate likely implant success among patients with type 2 diabetes who lacked good glycemic control. Further investigation, including longer-term evaluation, is needed.

AB - Background.The authors conducted a prospective cohort study to determine whether poor glycemic control is a contraindication to implant therapy in patients with type 2 diabetes.Methods. The study sample consisted of 117 edentulous patients, each of whom received two mandibular implants, for a total of 234 implants. Implant-retained mandibular overdentures were loaded after a four-month healing period and followed up for an additional one year. The authors assessed implant survival and stability (by means of resonance frequency analysis) relative to glycated hemoglobin A1c (HbA1c) levels, with baseline levels up to 11.1 percent and levels as high as 13.3 percent over one year.Results. Implant survival rates for 110 of 117 patients who were followed up for one year after loading were 99.0 percent, 98.9 percent and 100 percent, respectively, for patients who did not have diabetes (n = 47), those with well-controlled diabetes (n = 44) and those with poorly controlled diabetes (n = 19). The authors considered the seven patients lost to follow-up as having had failed implants; consequently, their conservative estimates of survival rates in the three groups were 93.0 percent, 92.6 percent and 95.0 percent (P = .6510). Two implants failed at four weeks, one in the nondiabetes group and the other in the well-controlled diabetes group. Delays in implant stabilization were related directly to poor glycemic control.Conclusions. The results of this study indicate that elevated HbA1c levels in patients with type 2 diabetes were not associated with altered implant survival one year after loading. However, alterations in early bone healing and implant stability were associated with hyperglycemia. Practical Implications. Within the clinical parameters of this study, the findings indicate likely implant success among patients with type 2 diabetes who lacked good glycemic control. Further investigation, including longer-term evaluation, is needed.

KW - Bone biology

KW - Diabetes

KW - Implant stability quotient

KW - Implantology

KW - Resonance frequency analysis

UR - http://www.scopus.com/inward/record.url?scp=84913611380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913611380&partnerID=8YFLogxK

U2 - 10.14219/jada.2014.93

DO - 10.14219/jada.2014.93

M3 - Article

VL - 145

SP - 1218

EP - 1226

JO - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 12

ER -